B16-huCD20 tumors treated with 177Lu-TRT were subjected to multiplex analysis to study the tumor immune signature.

Thomas Ertveldt (Creator)
Kirsten De Ridder (Creator)
Hanne Locy (Creator)
Karine Breckpot (Creator)

Dataset

1 Article
1 PhD Thesis

2 resultaten

2023
Radiolabeled single-domain antibodies as a means to evoke and monitor immunological responses in malignant lesions
Ertveldt, T., 2023, 177 blz.
Onderzoeksoutput: PhD Thesis

Open Access
Bestand
124 Downloads (Pure)
2022
Targeted radionuclide therapy with low and high-dose Lutetium-177 labeled single domain antibodies induces distinct immune signatures in a mouse melanoma model
Ertveldt, T., De Beck, L., De Ridder, K., Locy, H., De Mey, W., Goyvaerts, C., Lecocq, Q., Ceuppens, H., De Vlaeminck, Y., Awad, R. M., Keyaerts, M., Devoogdt, N., D'Huyvetter, M., Breckpot, K. & Krasniqi, A., jul. 2022, In: Molecular Cancer Therapeutics. 21, 7, blz. 1136-1148 13 blz.
Onderzoeksoutput: Article › peer review

Open Access
Bestand
16 Citaten (Scopus)

120 Downloads (Pure)